Related Experiment Video

Updated: May 10, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Paricalcitol and cardiorenal outcome: from the IMPACT study to clinical practice

Antonio Bellasi1, Andrea Galassi, Paolo Salvi

  • 1Department of Nephrology and Dialysis, Azienda Ospedaliera Sant'Anna, Como, Italy. antonio.bellasi@hsacomo.org

Blood Purification
|June 6, 2013
PubMed

Insights

Vitamin D deficiency is linked to poor outcomes in chronic kidney disease mineral and bone disorders (CKD-MBD). This review examines evidence on vitamin D

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiovascular Medicine

Background:

  • Chronic kidney disease mineral and bone disorders (CKD-MBD) present complex laboratory, vascular, and bone abnormalities.
  • The precise pathogenesis of CKD-MBD remains incompletely understood despite extensive research.
  • Vitamin D deficiency is a recognized early feature of CKD-MBD, associated with cardiovascular disease and mortality risk.

Purpose of the Study:

  • To review current evidence linking vitamin D deficiency to adverse outcomes in CKD patients.
  • To summarize recent clinical trial findings on the effects of paricalcitol supplementation on hard outcomes in CKD.

Main Methods:

  • Literature review of epidemiological studies on vitamin D levels and CKD-MBD outcomes.
  • Analysis of recent clinical trials investigating paricalcitol in CKD patients.

Main Results:

  • Epidemiological data consistently associate low serum vitamin D with adverse health markers and increased mortality in CKD populations.
  • Clinical trials exploring paricalcitol supplementation are evaluating its impact on major adverse cardiovascular events and overall survival.

Conclusions:

  • Vitamin D deficiency is a significant factor contributing to poor prognosis in CKD-MBD.
  • Further research and clinical trials are essential to fully elucidate the role of vitamin D and its analogs in managing CKD-MBD and improving patient outcomes.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...